In VITT, autoantibodies bind to platelet factor 4 (PF4), after which interaction with Fcy receptor IIA causes platelet activation and aggregation, with subsequent thrombosis and thrombocytopenia [4,5,7,8,9,10,11]. Here, PF4 is linked to deep vein thrombosis.